Physician profile
Brian P Murray
NPI 1083659072
$129,985.60
in general payments reported to CMS, 2019-2025
48 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $23K · 2021: $18K · 2022: $16K · 2023: $21K · 2024: $16K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Food and Beverage: $9,513 · Travel and Lodging: $3,417 · Consulting Fee: $1,660 · Education: $390 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,111.34 |
| Food and Beverage | $9,513.43 |
| Travel and Lodging | $3,416.92 |
| Consulting Fee | $1,660.00 |
| Education | $389.96 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29,029.69 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $24,324.05 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $17,072.35 | 2019-2023 | |
| Urovant Sciences INC | $16,794.13 | 2021-2022 | |
| Allergan, INC. | $16,348.39 | 2019-2022 | |
| Astellas Pharma US INC | $8,551.08 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $7,325.36 | 2019-2025 | Advantage System, Solyx Sis System, Axonics |
| Medline Industries LP | $2,025.00 | 2020 | |
| Caldera Medical, INC | $1,265.82 | 2022-2024 | Desara |
| Medtronic, INC. | $855.63 | 2021-2025 | Interstim |
| Coloplast Corp | $698.70 | 2019-2025 | Altis, Speedicath |
| Teleflex LLC | $545.04 | 2021-2025 | Barrigel, Urolift |
| Axonics, INC. | $543.88 | 2023-2024 | Bulkamid, Axonics |
| Janssen Biotech, INC. | $519.85 | 2019-2025 | Erleada |
| Medtronic USA, INC. | $495.12 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $459.54 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $450.35 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $312.38 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $207.04 | 2021-2025 | Prolaris, Myrisk |
| Olympus America INC. | $185.27 | 2023-2025 | Itind System |
| 180 Medical, INC. | $178.22 | 2022-2024 | Gentlecath Glide, Gentlecath |
| Koelis INC. | $177.59 | 2024 | |
| Procept Biorobotics Corporation | $156.98 | 2019-2025 | Aquabeam System |
| Tolmar Pharmaceuticals, INC. | $150.74 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $143.38 | 2019-2025 | Adstiladrin |
| Tolmar, INC. | $134.68 | 2023-2025 | Jatenzo, Eligard |
| Travere Therapeutics, INC. | $111.10 | 2019-2021 | |
| Clinical Laserthermia Systems Americas INC. | $104.64 | 2024 | Mobile Laser Unit |
| C. R. Bard, INC. & Subsidiaries | $90.97 | 2019-2025 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $84.47 | 2019-2023 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $78.33 | 2024-2025 | |
| Myovant Sciences INC. | $71.27 | 2021-2022 | |
| Neotract INC. | $59.60 | 2019-2020 | |
| Endo USA, INC. | $47.06 | 2025 | Xiaflex, Aveed |
| Rochester Medical Corporation | $45.48 | 2020-2022 | |
| Halozyme INC | $42.40 | 2023 | |
| Avadel Specialty Pharmaceuticals, LLC | $38.20 | 2019 | |
| Ethicon US, LLC | $32.97 | 2021 | |
| Laborie Medical Technologies Corp. | $31.18 | 2025 | |
| Dendreon Pharmaceuticals LLC | $30.32 | 2025 | Provenge |
| Ambu INC. | $26.77 | 2022 | |
| Dentsply Ih Ab | $25.80 | 2025 | Lofric |
| Accord Healthcare, INC. | $22.50 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.85 | 2025 | Givlaari |
| Amgen INC. | $19.21 | 2022 | |
| Profound Medical Corp. | $18.16 | 2025 | Tulsa-Pro |
| Hollister Incorporated | $16.87 | 2022 | |
| Mission Pharmacal Company | $16.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.